Nuveen Asset Management LLC trimmed its holdings in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 67.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 277,944 shares of the health services provider's stock after selling 570,672 shares during the period. Nuveen Asset Management LLC owned approximately 0.49% of Maximus worth $20,749,000 at the end of the most recent quarter.
Several other institutional investors have also recently made changes to their positions in the company. Vanguard Group Inc. increased its holdings in shares of Maximus by 3.2% during the 4th quarter. Vanguard Group Inc. now owns 6,548,284 shares of the health services provider's stock valued at $488,829,000 after purchasing an additional 205,564 shares in the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of Maximus by 14.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,406,592 shares of the health services provider's stock valued at $105,001,000 after purchasing an additional 177,075 shares in the last quarter. Van Berkom & Associates Inc. increased its holdings in shares of Maximus by 8.5% during the 4th quarter. Van Berkom & Associates Inc. now owns 1,256,418 shares of the health services provider's stock valued at $93,792,000 after purchasing an additional 98,264 shares in the last quarter. Fuller & Thaler Asset Management Inc. increased its holdings in shares of Maximus by 7.4% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 1,234,933 shares of the health services provider's stock valued at $92,188,000 after purchasing an additional 84,835 shares in the last quarter. Finally, Janus Henderson Group PLC increased its holdings in shares of Maximus by 2.0% during the 4th quarter. Janus Henderson Group PLC now owns 1,186,150 shares of the health services provider's stock valued at $88,546,000 after purchasing an additional 22,711 shares in the last quarter. 97.21% of the stock is owned by hedge funds and other institutional investors.
Insiders Place Their Bets
In other Maximus news, Director Jan Madsen sold 2,439 shares of Maximus stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total transaction of $165,144.69. Following the sale, the director now owns 18,097 shares of the company's stock, valued at $1,225,347.87. The trade was a 11.88% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.60% of the stock is currently owned by corporate insiders.
Maximus Price Performance
Maximus stock traded down $1.91 during trading on Wednesday, reaching $72.80. The company had a trading volume of 178,789 shares, compared to its average volume of 560,360. The firm's 50-day simple moving average is $69.59 and its 200 day simple moving average is $71.93. Maximus, Inc. has a 1-year low of $63.77 and a 1-year high of $93.97. The firm has a market capitalization of $4.10 billion, a PE ratio of 15.63 and a beta of 0.61. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.72 and a current ratio of 1.72.
Maximus (NYSE:MMS - Get Free Report) last released its quarterly earnings results on Thursday, May 8th. The health services provider reported $2.01 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.37 by $0.64. Maximus had a net margin of 5.28% and a return on equity of 21.95%. The firm had revenue of $1.36 billion for the quarter, compared to analysts' expectations of $1.29 billion. During the same quarter last year, the company earned $1.57 EPS. The firm's revenue for the quarter was up 1.0% compared to the same quarter last year. As a group, equities research analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.
Maximus Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Saturday, May 31st. Shareholders of record on Thursday, May 15th will be paid a dividend of $0.30 per share. The ex-dividend date is Thursday, May 15th. This represents a $1.20 annualized dividend and a yield of 1.65%. Maximus's dividend payout ratio (DPR) is presently 23.86%.
Analyst Ratings Changes
Separately, Wall Street Zen lowered shares of Maximus from a "buy" rating to a "hold" rating in a report on Thursday, May 15th.
View Our Latest Stock Report on Maximus
About Maximus
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
See Also

Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.